Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O15021
UPID:
MAST4_HUMAN
Alternative names:
-
Alternative UPACC:
O15021; A6NL49; B5ME48; E7EWQ5; J3QT34; Q05EE6; Q6ZN07; Q8N4X4; Q96LY3
Background:
Microtubule-associated serine/threonine-protein kinase 4, identified by the accession number O15021, plays a crucial role in cellular processes by interacting with microtubules. Its involvement in the regulation of microtubule dynamics underscores its importance in cell division, intracellular transport, and cellular structure maintenance.
Therapeutic significance:
Understanding the role of Microtubule-associated serine/threonine-protein kinase 4 could open doors to potential therapeutic strategies. Its pivotal role in cellular processes makes it a promising target for drug discovery, aiming to modulate its activity for therapeutic benefits.